ライフサイエンスコーパス: SARS coronavirus

1 gens such as Marburg virus, Nipah virus, and SARS coronavirus.

2 might be unique to the SUD and, thus, to the SARS coronavirus.

3 P-PMO showed low inhibitory activity against SARS coronavirus.

4 ected with H5N1 avian influenza virus or the SARS-coronavirus.

5 After challenge with SARS coronavirus, all monkeys in the control group shed

6 Here, we identify SARS coronavirus amino-terminal replicase products nsp1,

7 locker of severe acute respiratory syndrome (SARS) coronavirus and Ebola pseudotype virus.

8 sis, influenza, respiratory syncytial virus, SARS-Coronavirus and pneumonia.

9 og in the severe acute respiratory syndrome (SARS) coronavirus appears to be group 1-like in that it

10 how that the PLpro domains from the MERS and SARS coronaviruses can recognize and process the same su

11 A SARS-coronavirus challenge was given to all monkeys 28 d

12 that infection of human airway epithelia by SARS coronavirus correlates with the state of cell diffe

13 zate (PubChem CID 16725315) were tested in a SARS coronavirus (CoV) and Ebola virus-pseudotype infect

14 al structure of the N-terminal domain of the SARS coronavirus (CoV) nucleocapsid protein.

15 st the papain-like protease (PLpro) from the SARS coronavirus (CoV).

16 es of the severe acute respiratory syndrome (SARS) coronavirus (CoV) are sensitive to neutralization

17 lation of severe acute respiratory syndrome (SARS) coronavirus (CoV) from Himalayan palm civets (Pagu

18 model of severe acute respiratory syndrome (SARS) coronavirus (CoV) lung disease.

19 from the severe acute respiratory syndrome (SARS) coronavirus (CoV) that stimulated -1 PRF.

20 oteins of severe acute respiratory syndrome (SARS) coronavirus (CoV) to protective immunity by expres

21 nVs), and severe acute respiratory syndrome (SARS) coronavirus (CoV).

22 s against severe acute respiratory syndrome (SARS) coronavirus (CoV).

23 In 2002, severe acute respiratory syndrome (SARS)-coronavirus (CoV) appeared as a novel human virus

24 hat the respiratory tract is a major site of SARS-coronavirus (CoV) infection and disease morbidity.

25 Recent studies indicate that SARS-coronavirus (CoV) spike protein (S protein) and its

26 hods by: 1) identifying the sites explaining SARS coronavirus differences between human, bat and palm

27 The SARS coronavirus encodes a novel membrane protein 6 that

28 The severe acute respiratory syndrome (SARS) coronavirus encodes several RNA-processing enzymes

29 We expressed the complete SARS coronavirus envelope spike (S) protein from a recom

30 ot group 2-like, as would be expected by the SARS coronavirus group 2-like 3' UTR structure.

31 acting alone, can prevent replication of the SARS coronavirus in the lung, a promising observation fo

32 3 of the severe acute respiratory syndrome (SARS) coronavirus includes a "SARS-unique domain" (SUD)

33 lungs of severe acute respiratory syndrome (SARS)-coronavirus-infected humans.

34 We identified 32 studies of SARS coronavirus infection and severe influenza.

35 70, was among the best characterized against SARS coronavirus infection, showing weight loss and othe

36 Severe acute respiratory syndrome (SARS) coronavirus infection and growth are dependent on

37 odels for severe acute respiratory syndrome (SARS) coronavirus infection of humans are needed to eluc

38 The hepatitis associated with the SARS coronavirus, Isolated Ductular Hyperplasia in patie

39 combinant severe acute respiratory syndrome (SARS) coronavirus lacking the E gene (rSARS-CoV-DeltaE)

40 The SARS coronavirus main proteinase (SARS CoV main proteina

41 s) of the severe acute respiratory syndrome (SARS) coronavirus may encode determinants of virus virul

42 me entry site (IRES)-driven mRNAs, including SARS coronavirus mRNAs, hepatitis C virus (HCV), and cri

43 with BHPIV3/SARS-S induced the production of SARS-coronavirus-neutralising serum antibodies, indicati

44 Severe acute respiratory syndrome (SARS) coronavirus nonstructural protein 1 (nsp1) binds t

45 gand that was found to inhibit -1 PRF in the SARS coronavirus on the conformational dynamics of the S

46 The severe acute respiratory syndrome (SARS) coronavirus papain-like protease (PLpro) is a DUB

47 tivirals and vaccines, but also for studying SARS coronavirus pathogenesis.

48 rotein of severe acute respiratory syndrome (SARS) coronavirus plays important roles in both viral re

49 We found that SARS coronavirus replicase products can be detected by 4

50 tion, the severe acute respiratory syndrome (SARS) coronavirus replicated to high titers in the respi

51 COGs) database, Retroviral Genotyping Tools, SARS Coronavirus Resource, SAGEmap, Gene Expression Omni

52 A vectored mucosal vaccine expressing the SARS-coronavirus S protein alone may be highly effective

53 We previously showed that recombinant SARS coronavirus (SARS-CoV) (Urbani strain based) lackin

54 rotein microarray that harbors proteins from SARS coronavirus (SARS-CoV) and five additional coronavi

55 highly contagious disease that is caused by SARS coronavirus (SARS-CoV) and for which there are curr

56 ar receptor for two divergent coronaviruses, SARS coronavirus (SARS-CoV) and human coronavirus NL63 (

57 Despite the identification of SARS coronavirus (SARS-CoV) as the etiologic agent of SA

58 The spike protein (S) of SARS coronavirus (SARS-CoV) attaches the virus to its ce

59 SARS coronavirus (SARS-CoV) causes severe acute respirat

60 SARS coronavirus (SARS-CoV) encodes several unique group

61 The SARS coronavirus (SARS-CoV) has been identified as the e

62 rude fatality rate (around 50% vs. 10%) than SARS coronavirus (SARS-CoV) infection.

63 , for "middle of the SARS-unique domain") in SARS coronavirus (SARS-CoV) nonstructural protein 3 (nsp

64 pidemiologic studies have suggested that the SARS coronavirus (SARS-CoV) originated from animals.

65 tructures of NL63 coronavirus (NL63-CoV) and SARS coronavirus (SARS-CoV) receptor-binding domains (RB

66 ribe the construction of a panel of isogenic SARS coronavirus (SARS-CoV) strains bearing variant spik

67 evere acute respiratory syndrome (SARS), the SARS coronavirus (SARS-CoV), is a member of this large f

68 in-converting enzyme 2 (ACE2), isolated from SARS coronavirus (SARS-CoV)-permissive Vero E6 cells, th

69 Incidentally, ACE2 is also used by group II SARS coronavirus (SARS-CoV).

70 enzyme 2 (ACE2) is a functional receptor for SARS coronavirus (SARS-CoV).

71 s caused by a previously unknown coronavirus-SARS coronavirus (SARS-CoV).

72 ten fatal severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) infection.

73 rotein of severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) is not only responsible for

74 cation of severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) requires proteolytic proces

75 ) against severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) spike (S) glycoprotein conf

76 rotein of severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) were mapped by Pepscan anal

77 ks of the severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV), but concerns remain over t

78 TR in the severe acute respiratory syndrome (SARS) coronavirus (SCoV) can each replace the 301-nt 3'

79 Severe acute respiratory syndrome (SARS) coronavirus (SCoV) causes a recently emerged human

80 he elderly to severe SARS and the ability of SARS coronavirus to replicate in mice led us to examine

81 NL63 and severe acute respiratory syndrome (SARS) coronavirus to determine if DUB activity mediates

82 of the respiratory tract, the major site of SARS- coronavirus transmission and disease.

83 The severe acute respiratory syndrome (SARS) coronavirus virus non-structural protein 15 is a M

84 virus, all monkeys in the control group shed SARS coronavirus, with shedding lasting 5-8 days.